Want to see GB:MET full AI Analyst Report?
Microsaic Systems (MET) AI Stock Analysis
Microsaic Systems
(LSE:MET)
Overall, the stock scores low because ongoing large losses and persistent cash burn dominate the investment profile, only partly offset by a strong, low-debt balance sheet. Very weak technicals, with the price deeply below moving averages and momentum indicators in oversold territory, reinforce a cautious stance, while limited valuation support from negative earnings and no dividend offers little downside protection.
Microsaic Systems (MET) vs. iShares MSCI United Kingdom ETF (EWC)
- Market Cap
- GBP 1.22M
- Dividend Yield
- ―
- Average Volume (3M)
- 2.46M
- Price to Earnings (P/E)
- -0.8
- Beta (1Y)
- 0.82
- Revenue Growth
- ―
- EPS Growth
- ―
- Country
- UK
- Employees
- 5
- Sector
- Technology
- Sector Strength
- 61
- Industry
- Medical - Specialties
Microsaic Systems Business Overview & Revenue Model
Company Description
Metir Plc engages in the research, development, and commercialization of scientific instruments. It also develops mass spectrometry instruments for the analysis of gaseous, liquid, and solid samples. The company was founded in 2001 and is headquarter...
How the Company Makes Money
Microsaic Systems makes money primarily by selling analytical instrumentation and associated solutions. Its revenue model is centered on: (1) Product sales: selling mass spectrometers and integrated/related hardware used for chemical detection and qu...
Microsaic Systems Financial Statement Overview
Summary
Strong, low-leverage balance sheet partially offsets very weak profitability and persistent cash burn, resulting in a below-average but not distressed financial profile.
Income Statement
32NegativeBalance Sheet
71PositiveCash Flow
28Negative| Breakdown | TTM | Jun 2026 | Jun 2025 | Jun 2024 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 1.44M | 1.44M | 232.00K | 492.00K | 1.57M | 906.88K |
| Gross Profit | 531.00K | 488.00K | -125.00K | 13.00K | 949.37K | 380.65K |
| EBITDA | -791.00K | -799.00K | -1.76M | -2.31M | -2.25M | -3.19M |
| Net Income | -867.00K | -867.00K | -1.81M | -2.60M | -2.29M | -3.13M |
Balance Sheet | ||||||
| Total Assets | 2.01M | 2.01M | 1.40M | 713.00K | 3.13M | 5.16M |
| Cash, Cash Equivalents and Short-Term Investments | 1.06M | 1.06M | 188.00K | 173.00K | 1.24M | 3.46M |
| Total Debt | 5,000 | 5,000 | 19.00K | 21.00K | 56.25K | 127.34K |
| Total Liabilities | 778.00K | 778.00K | 1.22M | 569.00K | 408.08K | 581.92K |
| Stockholders Equity | 1.24M | 1.24M | 184.00K | 144.00K | 2.72M | 4.57M |
Cash Flow | ||||||
| Free Cash Flow | -767.00K | -801.00K | -1.85M | -1.07M | -2.34M | -1.94M |
| Operating Cash Flow | -767.00K | -767.00K | -1.66M | -1.06M | -2.13M | -1.60M |
| Investing Cash Flow | -34.00K | -34.00K | -175.00K | 48.00K | -211.95K | -334.22K |
| Financing Cash Flow | 1.67M | 1.67M | 1.84M | -59.00K | 121.89K | 5.01M |
Microsaic Systems Technical Analysis
Price Trends
Market Momentum
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For GB:MET, the sentiment is Negative. The current price of 0.28 is below the 20-day moving average (MA) of 0.28, below the 50-day MA of 0.49, and below the 200-day MA of 0.66, indicating a bearish trend. The MACD of -0.05 indicates Negative momentum. The RSI at 11.53 is Positive, neither overbought nor oversold. The STOCH value of 60.00 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for GB:MET.
Microsaic Systems Peers Comparison
Overall Rating
GB:TIDE50Neutral
GB:CTAI44Neutral
GB:AIQ42Neutral- GB:MET42Neutral
GB:RDT39Underperform
Financial Indicators
| Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
| Sector * | 61Neutral | $37.18B | 12.37 | -10.20% | 1.83% | 8.50% | -7.62% |
| GB:TIDE | 50Neutral | GBP 6.41M | 23.10 | 4.92% | ― | ― | ― |
| GB:CTAI | 44Neutral | GBP 932.01K | -2.17 | -14.59% | ― | 1341.50% | 60.00% |
| GB:AIQ | 42Neutral | GBP 4.53M | -10.45 | 33.06% | ― | -100.00% | -38.78% |
| GB:MET | 42Neutral | GBP 1.22M | -0.81 | -110.17% | ― | ― | ― |
| GB:RDT | 39Underperform | GBP 1.18M | -0.23 | 480.99% | ― | -1.56% | 55.81% |
* Technology Sector Average
Performance Comparison
| Show on chart | Ticker | Company Name | Price | Change | % Change |
|---|---|---|---|---|---|
| GB:MET | Microsaic Systems | 0.28 | -0.47 | -63.33% | |
| GB:TIDE | Crimson Tide | 97.50 | 32.50 | 50.00% | |
| GB:SYME | Supply@Me Capital Plc | 0.01 | 0.00 | 0.00% | |
| GB:CTAI | Catenae Innovation Plc | 0.07 | -0.28 | -80.88% | |
| GB:RDT | Rosslyn Data Technologies | 1.00 | -2.35 | -70.15% | |
| GB:AIQ | AIQ Limited | 7.00 | 1.00 | 16.67% |
Microsaic Systems Corporate Events
Metir Halts AIM Trading to Prepare Capital Raise Under New Access Window
PositiveMetir plc said it will use AIM’s newly introduced Capital Access Window to temporarily halt trading in its ordinary shares from 3:00 p.m. on 5 October, ahead of a planned capital raising. The mechanism allows AIM‑listed companies to pause...
Metir revenue hit by delays but pins growth hopes on PFAS, SRB and Qatar rollout
NegativeMetir reported a sharp revenue decline to £367,000 for the first half of 2026, as equipment sales slowed, QuickChek SRB production was temporarily halted and a major continuous toxicity monitoring project in Qatar was disrupted by conflict, alth...
Metir expands PFAS detection partnerships and boosts Asia-Pacific reach
PositiveMetir plc has strengthened its position in PFAS monitoring and water quality solutions through new collaborations and an expanded distribution network. The company’s miniaturised mass spectrometry technology underpins a growing portfolio focuse...
Metir Wins Strong Shareholder Backing as All AGM Resolutions Pass
PositiveMetir plc reported that all resolutions at its 6 August 2026 Annual General Meeting were passed by poll, including approval of the 2025 Annual Report and Accounts and the re-election of directors Chris Potts, Nigel Burton and Robert Moore. Shareholde...
Metir accelerates water monitoring rollout and prepares QuickChek SRB relaunch
PositiveMetir plc reported growing commercial momentum for its Microtox LX water toxicity platform, with rising production enabling sales from stock, expanded trials and 19 systems sold so far in 2026. The board expects the enlarging installed base to drive...
Metir Wins Long-Term Backing for Qatar Water Toxicity Monitoring Project
PositiveMetir has secured formal confirmation of long-term support for its Continuous Toxicity Monitoring project in Qatar, where its Modern Water division is the sole supplier of the CTM technology. Following a stakeholder meeting, a project confirmation le...
Metir strikes GCC-focused water monitoring and purification partnership with Portsmouth Aviation
PositiveMetir plc has signed a strategic Memorandum of Understanding with Portsmouth Aviation’s Paqua division to explore integrated water treatment and biological monitoring solutions. The partnership combines PaquaVida’s mobile water purificati...
Metir plc Publishes 2025 Annual Report and Sets Date for AGM
NeutralMetir plc has released its Notice of Annual General Meeting, confirming that the document, along with the 2025 Annual Report and Accounts and proxy form, is now available to shareholders and on the company’s website. The AGM will take place at...
Metir plc posts fivefold revenue jump as PFAS and pathogen platforms gain traction
PositiveMetir plc reported a transformative 2025, shifting from restructuring to strong commercial delivery in water and environmental monitoring. Revenue surged 521% to £1.44m on robust Microtox LX sales, growing reagent volumes and income recognition...
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.
Date of analysis: Oct 06, 2026